Machine Learning

ROHM's new SiC modules are now on DigiKey, democratizing access to next-gen power tech for EVs and industry, challenging market leaders.

With two key executive appointments, BST Global signals a strategic acceleration of its AI-powered project intelligence mission for the AEC industry.

Data shows Beren Therapeutics' drug slows progression and boosts survival for infantile-onset NPC, a rare disorder with no approved US treatments.

A European firm is bringing passive brain-computer interface tech to the US, promising safer AI but raising profound questions about mental privacy.

Genspark.ai launches its first 'AI employee,' crossing a $200M run rate and securing a $1.6B valuation in the race to automate knowledge work.

Rivian unveils the R2, a mid-size SUV starting around $45,000. It packs clever features and impressive range, but can the company scale production to meet demand?

A landmark review decodes how ketogenic diets treat epilepsy, highlighting a major research gap and sparking a quest for drugs that mimic the diet's effects.

New AI-powered features are transforming phone calls for people with hearing or speech disabilities, boosting confidence and making conversations feel natural.

A year-long undercover study reveals traditional exam proctoring is failing, putting the value of degrees and professional licenses at risk.

A new partnership combines advanced AI with human expertise to bring hope and clarity to 300 million people on a long, isolating journey to diagnosis.

Heather Peterson joins onPhase as CCO, signaling a strategic push to deliver rapid value to finance teams battling resource scarcity and tech overload.

A new integration with Concrete allows millions of Binance Wallet users to access sophisticated, risk-adjusted USDT yield strategies once reserved for institutions.

Global CRO Emerald Clinical Trials has won a major award for its patient-first strategies in the fast-growing, complex Asia-Pacific clinical trial market.

Fintech leader Momnt appoints Allyson Torsak as CRO, signaling a major push to capture the fragmented home improvement market with its advanced lending tech.

New data reveals developers are ditching hype for efficiency, with Alibaba's Qwen unseating Llama and modular tools defining the production landscape.

The biopharma nonprofit will tackle clinical trial modernization, AI integration, and the unfulfilled promise of real-world evidence at a key industry summit.

Tineco's FLOOR ONE S9 Artist Steam earns a "Worth the Hype" nod, signaling a new era where smart, all-in-one appliances redefine home cleaning.

The precision oncology firm reports a dramatic cut in net loss and a strategic pivot paying off, bolstered by a new U.S. patent for its cancer tech.

The merger of Fullmind and Elevate K-12 creates a dominant force in K-12 online learning, promising expanded services but raising market questions.

With new clinical data and a clear path to Phase 2 trials, Gain Therapeutics' GT-02287 offers hope for a disease-modifying therapy for Parkinson's.